Clearmind Medicine Appoints Mary-Elizabeth Gifford as Chief of Global Impact
Clearmind Medicine Inc., a clinical-stage biotech focused on neuroplastogens-derived therapeutics for under-treated health problems, has appointed Mary-Elizabeth Gifford as Chief of Global Impact as of October 20252346.
Gifford will lead Clearmind’s efforts to strengthen US partnerships, governmental and regulatory advocacy, and strategic alliances, focusing on advancing innovative psychedelic medicines in Washington, D.C. and New York23.
Prior to Clearmind, Gifford held the same title at Psyence BioMed, a Nasdaq-listed biopharma company focused on nature-derived psychedelic medicine, and has led public policy at the Center for Mind-Body Medicine2.
Clearmind currently has clinical trials underway at Yale School of Medicine, Johns Hopkins University School of Medicine, and Hadassah University Medical Center in Jerusalem; its Scientific Advisory Board includes faculty from Harvard, Yale, and the University of Pennsylvania2.
Clearmind Medicine is notable for its portfolio of 31 granted patents and aims to set an industry standard for scientific rigor and integrity in psychedelic therapeutics2.
Mary-Elizabeth Gifford chairs the Global Wellness Institute’s Psychedelics & Healing Initiative, with Rick Doblin of MAPS as honorary chair, and she is recognized as one of the most influential figures in psychedelic medicine policy2.
Her appointment signals Clearmind’s strategic focus on ethical and patient-centered delivery of psychedelic-derived treatments and increased engagement with US policymakers4.
Sources:
2. https://www.globenewswire.com/news-release/2025/10/27/3174673/0/en/Clearmind-Medicine-Appoints-Mary-Elizabeth-Gifford-as-Chief-of-Global-Impact-to-Advance-US-Partnerships-and-Governmental-Engagement.html
3. https://www.clearmindmedicine.com/news-release/clearmind-medicine-appoints-mary-elizabeth-gifford-as-chief-of-global-impact-to-advance-us-partnerships-and-governmental-engagement
4. https://stocks99.in/clearmind-medicine-global-impact-chief-2025/
6. https://www.aktiencheck.de/news/Artikel-ClearmindMedicineAppointsMaryElizabethGiffordasChiefofGlobalImpacttoAdvanceUSPartnershipsandGovernmental_Engagement-19145313